EUVIMEDEUVIMED entdecken
Kohortenstudie

Clinical Obesity and New‐Onset Atrial Fibrillation: A Population‐Based Cohort Study From the Kailuan Cohort

Yubing Guo, Hongmin Liu iD, Nan Zhang, Donglei Luo, Hao Wang, Gary Tse iD, Panagiotis Korantzopoulos, Gregory Y H Lip iD, Yunfei Gu, Shouling Wu iD, Tong Liu iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70893 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Yubing Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second H…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Obesity. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Tianjin Key Medical Discipline Construction.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Using the clinical obesity concept recently proposed by the Lancet Diabetes & Endocrinology Commission, this study evaluated the impact of clinical obesity on new‐onset atrial fibrillation (AF) in the general population.

Methods

Individuals who underwent first health examinations from June 2006 to October 2007 in Kailuan were included. Based on body mass index (BMI), waist circumference (WC), waist‐to‐height ratio (WHtR), waist‐to‐hip ratio (WHR), and presence of obesity‐related organ/tissue dysfunction, participants were divided into no obesity, preclinical obesity, and clinical obesity groups.

Results

A total of 98 730 participants free from AF at baseline were identified. Of these, 1343 developed new‐onset AF over a median follow‐up of 16.97 years. The AF incidence densities were 0.67, 0.68, and 1.25 per 1000 person‐years in the no obesity, preclinical, and clinical obesity groups, respectively. Compared to the no obesity group, the clinical obesity (HR: 1.29, 95% CI: 1.12–1.47) group showed increased risks of new‐onset AF. Clinical obesity remained associated with higher new‐onset AF risk in participants aged < 45 years (HR: 2.34, 95% CI: 1.42–3.86) and 45‐ < 60 years (HR: 1.40, 95% CI: 1.14–1.71). In men, clinical obesity was associated with 35% higher risks of new‐onset AF (HR: 1.34, 95% CI: 1.16–1.55). No significant association was observed between clinical obesity and new‐onset AF in participants with a history of using anti‐hypertensive agents (HR: 0.98, 95% CI: 0.73–1.30).

Conclusions

Clinical obesity is an independent risk factor for new‐onset AF, with age‐ and sex‐specific associations, while metabolic‐targeted therapies were associated with attenuated obesity‐associated new‐onset AF risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationObesityHumansMaleMiddle AgedFemaleChinaBody Mass IndexIncidenceRisk FactorsAdultCohort StudiesAgedWaist CircumferenceWaist-Hip RatioFollow-Up Studies

Stichwörter der Autor:innen

ageclinical obesitymetabolic‐targeted therapiesnew‐onset atrial fibrillationsex

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Department of Cardiology, Luoyang Central Hospital, Luoyang, China.
  • Department of Cardiology, Kailuan General Hospital, Tangshan, China.
  • School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong, China.
  • First Department of Cardiology, University of Ioannina Medical School, Ioannina, Greece.
  • Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.

ORCID-Profile: Hongmin Liu, Gary Tse, Gregory Y H Lip, Shouling Wu, Tong Liu

Förderung

  • Tianjin Key Medical Discipline Construction

Zitieren

APA

Guo, Y., Liu, H., Zhang, N., Luo, D., Wang, H., Tse, G., Korantzopoulos, P., Lip, G. Y. H., Gu, Y., Wu, S., & Liu, T. (2026). Clinical Obesity and New‐Onset Atrial Fibrillation: A Population‐Based Cohort Study From the Kailuan Cohort. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70893

Vancouver

Guo Y, Liu H, Zhang N, Luo D, Wang H, Tse G, et al. Clinical Obesity and New‐Onset Atrial Fibrillation: A Population‐Based Cohort Study From the Kailuan Cohort. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70893

BibTeX
@article{Guo2026,
  author = {Guo, Yubing and Liu, Hongmin and Zhang, Nan and Luo, Donglei and Wang, Hao and Tse, Gary and Korantzopoulos, Panagiotis and Lip, Gregory Y H and Gu, Yunfei and Wu, Shouling and Liu, Tong},
  title = {Clinical Obesity and New‐Onset Atrial Fibrillation: A Population‐Based Cohort Study From the Kailuan Cohort},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70893}
}
Kostenlos starten →